Universitätsklinikum Heidelberg

Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC) (2022) Reinisch M, Blohmer JU, Link T, Just M, Untch M, Stoetzer O, Fasching P, et al. Conference contribution Genetic characterization of advanced conjunctival melanoma and response to systemic treatment (2022) Lodde GC, Jansen P, Möller I, Sucker A, Hassel JC, Forschner A, Eckardt J, et al. Journal article Inflammation induces pro-NETotic neutrophils via TNFR2 signaling (2022) Neuenfeldt F, Schumacher JC, Grieshaber-Bouyer R, Habicht J, Schröder-Braunstein J, Gauss A, Merle U, et al. Journal article Stereotactic body radiotherapy of adrenal metastases-A dose-finding study (2022) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Journal article Clinical Practice Guideline: Patients with multiple myeloma or monoclonal gammopathy of undetermined significance - Diagnosis, treatment, and follow-up Patienten mit multiplem Myelom oder mit monoklonaler Gammopathie unklarer Signifikanz (2022) Piechotta V, Skoetz N, Engelhardt M, Einsele H, Goldschmidt H, Scheid C Journal article Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference (2022) Kolberg-Liedtke C, Lueftner D, Brucker SY, Budach W, Denkert C, Fasching P, Haidinger R, et al. Journal article Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation (2022) Polymeris AA, Meinel TR, Oehler H, Hoelscher K, Zietz A, Scheitz JF, Nolte CH, et al. Journal article High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma (2022) Koch R, Gelderblom H, Haveman L, Brichard B, Jürgens H, Cyprova S, Van Den Berg H, et al. Journal article Beyond founder and truncting variants in TECPR2-associated disorder (2022) Neuser S, Brechmann B, Heimer G, Brosse I, Schubert S, O'Grady L, Zech M, et al. Conference contribution Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma (2022) Bijlsma MF, Bailey PJ, Stemmler M Journal article